| 标题 |
Benmelstobart plus anlotinib versus pembrolizumab as first-line treatment for PD-L1-positive, advanced non-small-cell lung cancer (CAMPASS): a blinded, randomised, controlled, phase 3 trial |
| 网址 | |
| DOI | |
| 其它 |
期刊:Lancet Oncology 作者:Hua Zhong; Jing Wang; Runxiang Yang; Yongzhong Luo; Wei Zuo; et al 出版日期:2026-03-10 |
| 求助人 | |
| 下载 |
PDF的下载单位、IP信息已删除
(2025-6-4)